Mike Johnson (pseudonym), a 32-year-old social media live-streamer, had long suffered from obesity due to irregular work and rest. His weight soared to 100.8kg, with a BMI of 32.1kg/m² and a visceral fat level of 10 (normal range 1-9, levels above 7 indicate severe excess). "I got out of breath after climbing two floors and often felt listless during live streams. My family kept urging me to lose weight every physical exam," Mike recalled. He had previously tried various weight loss methods such as gym training, dieting, and meal replacements, but all failed—either due to busy live-stream schedules or overeating caused by extreme hunger.
In November 2024, after evaluation by Dr. Emily Davis from the Endocrinology Department of Mayo Clinic, Mike met the clinical indications for Semaglutide (weight loss version, Wegovy®)—BMI ≥30kg/m² with visceral fat excess. The doctor formulated a comprehensive plan combining medication and lifestyle intervention: an initial dose of 0.25mg subcutaneous injection weekly, gradually increasing to 2.4mg (recommended weight loss dose) after 4 weeks based on tolerance; combined with a low-fat, high-protein diet designed by a nutritionist and a requirement of 30 minutes of brisk walking daily.
In the early stage of medication, Mike experienced mild gastrointestinal discomfort: "I felt full after eating a quarter of my normal meal and occasionally had bloating," but this reaction gradually subsided after two weeks. What surprised him more was that the satiety brought by the medication helped him easily get rid of the habit of late-night snacks. "I used to have hamburgers and fries after late-night live streams, but now a piece of sugar-free whole wheat cake is enough to keep me full. I gradually developed the good habit of eating breakfast," he said. In the first month of medication, he lost 3kg without deliberately increasing exercise, and his visceral fat level dropped to 9.
After 3 months of consistent medication, Mike's weight stabilized at 91kg, with a total weight loss of 9.8kg. His BMI decreased to 29.0kg/m² and his visceral fat level dropped to 7. More importantly, his sleep quality improved significantly, and his mental state during live streams was completely renewed. "Now I take the initiative to walk briskly for 40 minutes every morning, and vegetables that I didn't like before have become regulars on my table," Mike said. Doctor's monitoring showed that his blood glucose, blood lipid and other metabolic indicators returned to normal without serious side effects.
Dr. Emily Davis emphasized that Mike's success came from the combination of standardized medication and lifestyle adjustment: "Semaglutide works by suppressing appetite and delaying gastric emptying, but it is a prescription drug that can only be used after doctor evaluation. For patients like Mike with qualified BMI and metabolic abnormalities, medication under professional guidance can balance efficacy and safety." The doctor also reminded that healthy habits must be maintained for a long time after stopping medication to avoid weight regain.
